🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A Phase 1/2 Open-label Study in Patients with Arginase I Deficiency to Inve...
Status
Completed
Location
Stanford University School of Medicine
Start Date
2016-06
Trial ID
NCT02488044
Treatments Being Tested
CAEB1102-300A is a multi-center randomized, double-blind, placebo-controlle...
Status
Completed
Location
Harvey Pediatrics
Start Date
2019-05-01
Trial ID
NCT03921541
Treatments Being Tested
The purpose of this study is to investigate the long-term safety, tolerabil...
Status
Completed
Location
Stanford University School of Medicine
Start Date
2017-12-07
Trial ID
NCT03378531
Treatments Being Tested
This is the first study of the safety of increasing dose levels of AEB1102 ...
Status
Completed
Location
Comprehensive Cancer Center at University of Michigan
Start Date
2016-08-15
Trial ID
NCT02732184
Treatments Being Tested
This is an open-label, multicenter study to evaluate the safety of weekly S...
Status
Terminated
Location
Hospital for Sick Children
Start Date
2023-04-04
Trial ID
NCT05676853
Treatments Being Tested
The main purpose of this Phase 1/2 study is to determine the safety and eff...
Status
Completed
Location
University of Alabama, Mitchell Cancer Institute
Start Date
2017-12-21
Trial ID
NCT03371979
Treatments Being Tested
A first-in-human study of the safety of increasing dose levels of AEB1102 i...
Status
Completed
Location
Pinnacle Research
Start Date
2015-10-22
Trial ID
NCT02561234
Treatments Being Tested